At close: December 31 at 1:53:55 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
383.8010
383.8010
1.5650
147.1310
150.6220
Cost of Revenue
530.1810
530.1810
212.2130
256.5140
236.1570
Gross Profit
-146.3800
-146.3800
-210.6480
-109.3830
-85.5350
Operating Expense
13,485.2810
13,485.2810
379.4950
13.9110
231.5700
Operating Income
-13,631.6610
-13,631.6610
-590.1430
-123.2940
-317.1050
Net Non Operating Interest Income Expense
121.2850
121.2850
20.5890
31.0690
33.0960
Pretax Income
-13,510.3800
-13,510.3800
-572.4360
296.6540
-281.1980
Net Income Common Stockholders
-18,846.5010
-18,846.5010
-563.5700
-69.1590
-326.6800
Diluted NI Available to Com Stockholders
-18,846.5010
-18,846.5010
-563.5700
-69.1590
-326.6800
Basic EPS
-0.00
-0.05
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.05
-0.00
-0.00
-0.00
Basic Average Shares
273,743.5040
383,149.8440
273,743.5040
261,249.2460
233,769.7400
Diluted Average Shares
273,743.5040
383,149.8440
273,743.5040
261,249.2460
233,769.7400
Total Operating Income as Reported
-753.1780
-753.1780
-590.1440
-123.2940
-317.1050
Total Expenses
14,015.4620
14,015.4620
591.7080
270.4250
467.7270
Net Income from Continuing & Discontinued Operation
-13,510.3800
-13,510.3800
-572.4370
296.6540
-281.1990
Normalized Income
-13,510.3800
-13,510.3800
-572.4370
11.7695
-281.1990
Interest Income
254.2780
254.2780
77.1590
52.7480
35.5130
Interest Expense
132.9930
132.9930
56.5700
21.6790
2.4170
Net Interest Income
121.2850
121.2850
20.5890
31.0690
33.0960
EBIT
-13,377.3870
-13,377.3870
-515.8660
318.3330
-278.7810
EBITDA
-450.6700
-450.6700
-507.7480
325.4680
-268.6110
Reconciled Cost of Revenue
530.1810
530.1810
212.2130
256.5140
236.1570
Reconciled Depreciation
12,926.7170
12,926.7170
8.1180
7.1350
10.1700
Net Income from Continuing Operation Net Minority Interest
-13,510.3800
-13,510.3800
-572.4370
296.6540
-281.1990
Total Unusual Items Excluding Goodwill
0.0230
--
--
387.5980
--
Total Unusual Items
0.0230
--
--
387.5980
--
Normalized EBITDA
-450.6700
-450.6700
-507.7480
-62.1300
-268.6110
Tax Rate for Calcs
--
--
--
0.0003
--
Tax Effect of Unusual Items
--
--
--
102.7135
--
12/31/2020 - 12/21/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AELIS.PA Aelis Farma SA
2.0000
-1.96%
ALDVI.PA Advicenne S.A.
1.9700
-0.81%
ALACT.PA Acticor Biotech SAS
0.2500
0.00%
ABNX.PA ABIONYX Pharma SA
1.1900
-1.65%
ALBPS.PA Biophytis S.A.
0.3799
+5.18%
ALPAT.PA Plant Advanced Technologies SA
11.90
-0.83%
ALVET.PA TheraVet SA
0.1050
0.00%
MAAT.PA MaaT Pharma SA
7.96
-0.75%
ALINT.PA IntegraGen SA
0.5650
+10.78%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0750
+5.34%